Baseline plasma profiling identified three molecular states previously characterized in tissue: androgen receptor (AR)-high/metabolic, ...
Programs span familial and sporadic ALS, advancing Arbor’s strategic focus on the diseaseFirst CNS investigational new drug ...
Clinical Trials Arena on MSN
HealthBio begins multi-centre trial of Inflamexa for PTLDS
The trial plans to enrol around 252 patients across at least six sites in US where Lyme disease is endemic.
Lillian Chiang, Founder and CEO of Doylestown, Pennsylvania-based Evrys Bio, has received the Timothy M. Block Biotech Impact ...
1don MSN
Scientists are rewinding the biological clock inside human eyes—and patients say they can see again
Epigenetic reprogramming is rewriting what we thought we knew about permanent vision loss.
("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage biotechnology company developing gene therapies designed to ...
Reflector Bio, a New York-based biotechnology startup developing artificial intelligence models for drug discovery, has emerged from stealth with a... Read More ...
Pla2g2f enzyme gene preserves memory with age and resists dementia Lipid-clearing brain enzyme linked to resilient memory and ...
Immunotherapy with checkpoint inhibitors has revolutionized cancer therapy and enabled considerable therapeutic advances for ...
Harvard Researchers Identify Fat-Breaking Enzyme Gene as Key to Reversing Age-Related Memory Decline
Researchers at Harvard Medical School's Massachusetts General Hospital have published findings in Nature Neuroscience showing that the ...
Element Biosciences, Inc. today announced the first shipment of Cytos™, a first-of-its-kind multiomics workflow that captures guide RNA, cell morphology, protein expression, and whole transcriptome ...
A D-configured gold-nanorod and cerium-oxide composite combined near-infrared heating with antioxidant activity to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results